⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage iva differentiated thyroid gland carcinoma ajcc v8

Every month we try and update this database with for stage iva differentiated thyroid gland carcinoma ajcc v8 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid CancerNCT04061980
BRAF NP_004324....
BRAF V600E Muta...
Metastatic Thyr...
Refractory Thyr...
Stage IV Differ...
Stage IVA Diffe...
Stage IVB Diffe...
Binimetinib
Encorafenib
Nivolumab
18 Years - Providence Health & Services
Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid CancerNCT04061980
BRAF NP_004324....
BRAF V600E Muta...
Metastatic Thyr...
Refractory Thyr...
Stage IV Differ...
Stage IVA Diffe...
Stage IVB Diffe...
Binimetinib
Encorafenib
Nivolumab
18 Years - Providence Health & Services
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: